-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Reviva Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $277K.
- Reviva Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.26M.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $260K.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$11.9K, a 101% decline from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $1.59M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)